Biocept provides update on covid-19 testing with more than 100,000 samples received

San diego, nov. 12, 2020 /prnewswire/ -- biocept, inc. (nasdaq: bioc), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its covid-19 testing with more than 100,000 samples received to date for...
BIOC Ratings Summary
BIOC Quant Ranking